Vitamin A and retinol-binding protein in patients with myelomatosis and cancer of epithelial origin.
Serum vitamin A and retinol-binding protein (RBP) concentrations were measured in patients comprising 53 myeloma and 28 epithelial cell cancer cases. Vitamin A levels in these patients were found to be significantly lower than those in the 30 healthy subjects, the effect being more marked in the patients with cancer of epithelial origin. The serum concentrations of retinol-binding protein (RBP) fell in parallel with vitamin A in the epithelial cancer patients, while the RBP concentrations remained unaffected in the patients with myeloma, suggesting that the underlying factor for resulting low vitamin A levels may be different in these two groups of patients.
D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000097:blood; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000097:blood; D008297:Male; D008558:Melphalan / Q000627:therapeutic use; D008875:Middle Aged; D009101:Multiple Myeloma / Q000097:blood* / Q000188:drug therapy; D012177:Retinol-Binding Proteins / Q000097:blood*; D001749:Urinary Bladder Neoplasms / Q000097:blood; D014594:Uterine Neoplasms / Q000097:blood; D014801:Vitamin A / Q000097:blood*
D012177:Retinol-Binding Proteins; D014801:Vitamin A; D008558:Melphalan